2022 Speaker Profile

Ashley is a member of the Project Baseline team at Verily, Alphabet’s healthcare and life sciences arm. Her expertise includes product development across pharmaceutical, medical devices, and software companies. She led data management for the launch of Gilead’s Hep C cure, SovaldiⓇ. Prior to that, Ashley worked at several neuro-marketing organizations developing algorithms to understand consumer health behavior.

 

Ashley is committed to changing the clinical trial landscape, and believes that information sharing is a key component of empowering people to own their health.  As a patient herself, she enjoys the challenge of breaking down barriers within healthcare to drive better care. Ashley holds a BS in Cognitive Science- Neuroscience from University of California, San Diego.